Project information
Intercellular signalling in development and disease
- Project Identification
- GD204/09/H058
- Project Period
- 1/2009 - 12/2012
- Investor / Pogramme / Project type
-
Czech Science Foundation
- Doctor grants
- MU Faculty or unit
- Faculty of Science
- Keywords
- intercellular signalling in development, Wnt, model organisms
- Cooperating Organization
-
Institute of Biophysics
- Responsible person prof. RNDr. Jan Vondráček, Ph.D.
- Responsible person RNDr. Zbyněk Kozmik, CSc.
- Responsible person Doc. RNDr. Marek Jindra, CSc.
- Responsible person Masako Asahina Jindrová, Ph.D.
Publications
Total number of publications: 24
2011
-
Analysis of potentially biclonal CLL patients with two or three productive IGH rearrangements.
Year: 2011, type: Conference abstract
-
Analýza biklonálních /bifenotypických případů chronické lymfocytární leukemie.
Year: 2011, type: Conference abstract
-
Double/Triple productive immunoglobulin rearrangements in chronic lymphocytic leukemia patients
Year: 2011, type: Conference abstract
-
Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6
January 2011, year: 2011, volume: 31, edition: 1, DOI
-
Post-translational modifications regulate signalling by Ror1
Acta Physiologica, year: 2011, volume: 203, edition: 3, DOI
-
Sequential activation and inactivation of dishevelled in the Wnt/{beta}-catenin pathway by casein kinases.
Journal of Biological Chemistry, year: 2011, volume: 286, edition: 12, DOI
-
The interplay of the aryl hydrocarbon receptor and beta-catenin alters both AhR-dependent transcription and Wnt/beta catenin signaling in liver progenitors.
Toxicological sciences, year: 2011, volume: 122, edition: 2, DOI
-
Wnt/PCP pathway regulates B-cell migration in chronic lymphocytic leukemia
Year: 2011, type: Conference abstract
-
WNT-5A stimulates the GDP/GTP exchange at pertussis toxin-sensitive heterotrimeric G proteins.
Cell Signal, year: 2011, volume: 23, edition: 3, DOI
2010
-
Clonal evolution of malignant populations in potentially biclonal chronic lymphocytic leukemia patients.
Year: 2010, type: Conference abstract